Search Results - "Shoham, Gal"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Efficacy of Pembrolizumab vs. Nivolumab Plus Ipilimumab in Metastatic NSCLC in Relation to PD-L1 and TMB Status by Shalata, Walid, Maimon Rabinovich, Natalie, Agbarya, Abed, Yakobson, Alexander, Dudnik, Yulia, Abu Jama, Ashraf, Cohen, Ahron Yehonatan, Shalata, Sondos, Abu Hamed, Ahmad, Ilan Ber, Tahel, Machluf, Oshri, Shoham Levin, Gal, Meirovitz, Amichay

    Published in Cancers (10-05-2024)
    “…The efficacy of immune checkpoint inhibitor (ICI) therapy concerning programmed death ligand 1 (PD-L1) status is well established in patients diagnosed with…”
    Get full text
    Journal Article
  2. 2

    A new point mutation affecting the fourth transmembrane domain of PMP22 results in severe, de novo Charcot-Marie-Tooth disease by NAVON, R, SEIFRIED, B, GAL-ON, N. S, SADEH, M

    Published in Human genetics (01-05-1996)
    “…A novel T-->G mutation in exon 4 of the PMP22 gene was identified heterozygously in a girl with severe, de novo CMT1A disease. Duplication of the chromosomal…”
    Get full text
    Journal Article
  3. 3

    Robust CATE Estimation Using Novel Ensemble Methods by Machluf, Oshri, Frostig, Tzviel, Shoham, Gal, Milo, Tomer, Berkman, Elad, Pryluk, Raviv

    Published 04-07-2024
    “…The estimation of Conditional Average Treatment Effects (CATE) is crucial for understanding the heterogeneity of treatment effects in clinical trials. We…”
    Get full text
    Journal Article